US Stock MarketDetailed Quotes

VRCA Verrica Pharmaceuticals

Watchlist
  • 0.438
  • -0.007-1.57%
Close Mar 27 16:00 ET
  • 0.470
  • +0.032+7.41%
Post 18:48 ET
40.15MMarket Cap-0.30P/E (TTM)

Verrica Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-57.94%-60.93M
-10.73%-16.06M
42.22%-8.56M
-250.35%-16.36M
-334.58%-19.95M
-106.85%-38.58M
-192.83%-14.51M
-911.56%-14.81M
34.98%-4.67M
44.96%-4.59M
Net income from continuing operations
-14.31%-76.58M
34.18%-16.2M
7.83%-22.86M
-56.38%-17.19M
-208.56%-20.33M
-173.59%-67M
-314.94%-24.61M
-29,981.93%-24.8M
-8.08%-10.99M
22.21%-6.59M
Operating gains losses
7.65%2.73M
4.60%2.59M
--0
----
----
76.55%2.54M
--2.48M
----
----
----
Depreciation and amortization
51.79%1.27M
16.59%253K
62.86%342K
61.35%334K
68.32%340K
16.43%836K
7.96%217K
-34.58%210K
111.22%207K
106.12%202K
Other non cash items
172.35%2.21M
34.53%635K
--572K
--516K
--483K
108.23%810K
4,190.91%472K
----
----
----
Change In working capital
-79.44%2.03M
-184.06%-4.09M
4,021.71%11.02M
-152.32%-2.39M
-457.18%-2.51M
647.72%9.86M
1,269.95%4.87M
73.91%-281K
229.73%4.57M
141.52%703K
-Change in receivables
210.44%4.34M
57.56%-146K
363.58%10.28M
-2,135.04%-2.62M
-837.12%-3.18M
-706.78%-3.93M
-405.88%-344K
-1,839.80%-3.9M
-154.93%-117K
200.00%431K
-Change in prepaid assets
-292.16%-1.13M
188.33%371K
106.00%113K
-120.74%-337K
-200.71%-1.28M
228.73%587K
41.67%-420K
-140.31%-1.88M
218.00%1.63M
135.75%1.27M
-Change in payables and accrued expense
-106.39%-862K
-174.57%-4.25M
-86.97%727K
-79.59%640K
319.57%2.02M
2,375.21%13.49M
1,189.14%5.7M
23,345.83%5.58M
330.63%3.14M
47.10%-920K
-Change in other current liabilities
-10.65%-322K
0.00%-67K
-25.97%-97K
-8.22%-79K
-6.76%-79K
-10.23%-291K
4.29%-67K
-13.24%-77K
-10.61%-73K
-23.33%-74K
Cash from discontinued investing activities
Operating cash flow
-57.94%-60.93M
-10.73%-16.06M
42.22%-8.56M
-250.35%-16.36M
-334.58%-19.95M
-106.85%-38.58M
-192.83%-14.51M
-911.56%-14.81M
34.98%-4.67M
44.96%-4.59M
Investing cash flow
Cash flow from continuing investing activities
94.75%-19K
103.52%8K
75.38%-16K
81.36%-11K
0
-100.67%-362K
-103.36%-227K
-103.14%-65K
-102.68%-59K
-100.03%-11K
Net PPE purchase and sale
94.75%-19K
103.52%8K
75.38%-16K
81.36%-11K
--0
-19.87%-362K
-243.94%-227K
15.58%-65K
61.69%-59K
-120.00%-11K
Cash from discontinued investing activities
Investing cash flow
94.75%-19K
103.52%8K
75.38%-16K
81.36%-11K
--0
-100.67%-362K
-103.36%-227K
-103.14%-65K
-102.68%-59K
-100.03%-11K
Financing cash flow
Cash flow from continuing financing activities
-49.16%37.73M
140,907.14%39.43M
-100.90%-397K
-661.90%-640K
-102.18%-661K
539.91%74.21M
-28K
361.37%44.04M
-8,300.00%-84K
168,322.22%30.28M
Net issuance payments of debt
-104.68%-2.06M
-6,482.61%-1.51M
-100.49%-217K
--332K
---665K
200.75%44.08M
---23K
200.81%44.11M
--0
--0
Net common stock issuance
30.82%39.64M
3,963,800.00%39.64M
--0
--0
--0
12.64%30.3M
---1K
--0
--0
--30.3M
Proceeds from stock option exercised by employees
2,114.29%155K
--1K
--0
--150K
-42.86%4K
--7K
--0
--0
--0
--7K
Net other financing activities
----
----
-195.08%-180K
----
----
-935.29%-176K
---3K
---61K
---84K
-64.71%-28K
Cash from discontinued financing activities
Financing cash flow
-49.16%37.73M
146,122.22%39.43M
-100.90%-397K
-661.90%-640K
-102.18%-661K
539.91%74.21M
---27K
361.37%44.04M
-8,300.00%-84K
168,322.22%30.28M
Net cash flow
Beginning cash position
102.92%69.55M
-72.77%22.96M
-42.09%31.93M
-18.37%48.94M
102.92%69.55M
117.58%34.27M
159.62%84.31M
21.37%55.14M
18.94%59.95M
117.58%34.27M
Current changes in cash
-165.82%-23.22M
258.32%23.37M
-130.76%-8.97M
-253.47%-17.01M
-180.25%-20.61M
90.45%35.27M
-920.06%-14.76M
325.11%29.17M
3.32%-4.81M
-25.90%25.68M
End cash Position
-33.38%46.33M
-33.38%46.33M
-72.77%22.96M
-42.09%31.93M
-18.37%48.94M
102.92%69.55M
102.92%69.55M
159.62%84.31M
21.37%55.14M
18.94%59.95M
Free cash flow
-56.54%-60.95M
-9.03%-16.06M
42.36%-8.57M
-246.21%-16.37M
-333.54%-19.95M
-105.46%-38.94M
-193.51%-14.73M
-951.03%-14.88M
35.54%-4.73M
44.87%-4.6M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -57.94%-60.93M-10.73%-16.06M42.22%-8.56M-250.35%-16.36M-334.58%-19.95M-106.85%-38.58M-192.83%-14.51M-911.56%-14.81M34.98%-4.67M44.96%-4.59M
Net income from continuing operations -14.31%-76.58M34.18%-16.2M7.83%-22.86M-56.38%-17.19M-208.56%-20.33M-173.59%-67M-314.94%-24.61M-29,981.93%-24.8M-8.08%-10.99M22.21%-6.59M
Operating gains losses 7.65%2.73M4.60%2.59M--0--------76.55%2.54M--2.48M------------
Depreciation and amortization 51.79%1.27M16.59%253K62.86%342K61.35%334K68.32%340K16.43%836K7.96%217K-34.58%210K111.22%207K106.12%202K
Other non cash items 172.35%2.21M34.53%635K--572K--516K--483K108.23%810K4,190.91%472K------------
Change In working capital -79.44%2.03M-184.06%-4.09M4,021.71%11.02M-152.32%-2.39M-457.18%-2.51M647.72%9.86M1,269.95%4.87M73.91%-281K229.73%4.57M141.52%703K
-Change in receivables 210.44%4.34M57.56%-146K363.58%10.28M-2,135.04%-2.62M-837.12%-3.18M-706.78%-3.93M-405.88%-344K-1,839.80%-3.9M-154.93%-117K200.00%431K
-Change in prepaid assets -292.16%-1.13M188.33%371K106.00%113K-120.74%-337K-200.71%-1.28M228.73%587K41.67%-420K-140.31%-1.88M218.00%1.63M135.75%1.27M
-Change in payables and accrued expense -106.39%-862K-174.57%-4.25M-86.97%727K-79.59%640K319.57%2.02M2,375.21%13.49M1,189.14%5.7M23,345.83%5.58M330.63%3.14M47.10%-920K
-Change in other current liabilities -10.65%-322K0.00%-67K-25.97%-97K-8.22%-79K-6.76%-79K-10.23%-291K4.29%-67K-13.24%-77K-10.61%-73K-23.33%-74K
Cash from discontinued investing activities
Operating cash flow -57.94%-60.93M-10.73%-16.06M42.22%-8.56M-250.35%-16.36M-334.58%-19.95M-106.85%-38.58M-192.83%-14.51M-911.56%-14.81M34.98%-4.67M44.96%-4.59M
Investing cash flow
Cash flow from continuing investing activities 94.75%-19K103.52%8K75.38%-16K81.36%-11K0-100.67%-362K-103.36%-227K-103.14%-65K-102.68%-59K-100.03%-11K
Net PPE purchase and sale 94.75%-19K103.52%8K75.38%-16K81.36%-11K--0-19.87%-362K-243.94%-227K15.58%-65K61.69%-59K-120.00%-11K
Cash from discontinued investing activities
Investing cash flow 94.75%-19K103.52%8K75.38%-16K81.36%-11K--0-100.67%-362K-103.36%-227K-103.14%-65K-102.68%-59K-100.03%-11K
Financing cash flow
Cash flow from continuing financing activities -49.16%37.73M140,907.14%39.43M-100.90%-397K-661.90%-640K-102.18%-661K539.91%74.21M-28K361.37%44.04M-8,300.00%-84K168,322.22%30.28M
Net issuance payments of debt -104.68%-2.06M-6,482.61%-1.51M-100.49%-217K--332K---665K200.75%44.08M---23K200.81%44.11M--0--0
Net common stock issuance 30.82%39.64M3,963,800.00%39.64M--0--0--012.64%30.3M---1K--0--0--30.3M
Proceeds from stock option exercised by employees 2,114.29%155K--1K--0--150K-42.86%4K--7K--0--0--0--7K
Net other financing activities ---------195.08%-180K---------935.29%-176K---3K---61K---84K-64.71%-28K
Cash from discontinued financing activities
Financing cash flow -49.16%37.73M146,122.22%39.43M-100.90%-397K-661.90%-640K-102.18%-661K539.91%74.21M---27K361.37%44.04M-8,300.00%-84K168,322.22%30.28M
Net cash flow
Beginning cash position 102.92%69.55M-72.77%22.96M-42.09%31.93M-18.37%48.94M102.92%69.55M117.58%34.27M159.62%84.31M21.37%55.14M18.94%59.95M117.58%34.27M
Current changes in cash -165.82%-23.22M258.32%23.37M-130.76%-8.97M-253.47%-17.01M-180.25%-20.61M90.45%35.27M-920.06%-14.76M325.11%29.17M3.32%-4.81M-25.90%25.68M
End cash Position -33.38%46.33M-33.38%46.33M-72.77%22.96M-42.09%31.93M-18.37%48.94M102.92%69.55M102.92%69.55M159.62%84.31M21.37%55.14M18.94%59.95M
Free cash flow -56.54%-60.95M-9.03%-16.06M42.36%-8.57M-246.21%-16.37M-333.54%-19.95M-105.46%-38.94M-193.51%-14.73M-951.03%-14.88M35.54%-4.73M44.87%-4.6M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Alibaba
BABA
+2.56%
Apple
AAPL
+1.05%
Intel
INTC
+0.85%
Netflix
NFLX
+0.63%
Tesla
TSLA
+0.39%

Unlock the Full List